Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis. | Cancer Manag Res | 2021 | 33688252 | PubTator, text mining | PubMed |
| Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton's Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia. | Drug Des Devel Ther | 2021 | 33688166 | PubTator, text mining | PubMed |
| Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies. | J Hematol Oncol | 2021 | 33676527 | PubTator, text mining | PubMed |
| CD28 Gene Polymorphisms in the Promoter Region Are Associated with Transfusion Reactions: A Functional Study. | J Clin Med | 2021 | 33672525 | PubTator, text mining | PubMed |
| Targeted Treatment of Follicular Lymphoma. | J Pers Med | 2021 | 33671658 | PubTator, text mining | PubMed |
| Immune gene expression networks in sepsis: A network biology approach. | PLoS One | 2021 | 33667236 | PubTator, text mining | PubMed |
| [Antineoplasic drug repurposing in hematology for COVID-19 treatment]. | Bull Cancer | 2021 | 33663776 | PubTator, text mining | PubMed |
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922). | Melanoma Res | 2021 | 33661190 | PubTator, text mining | PubMed |
| Rapid Identification of Inhibitors and Prediction of Ligand Selectivity for Multiple Proteins: Application to Protein Kinases. | J Phys Chem B | 2021 | 33651624 | PubTator, text mining | PubMed |
| Hemophagocytic lymphohistiocytosis and myelodysplastic syndrome: a case report and review of the literature. | J Med Case Rep | 2021 | 33648567 | PubTator, text mining | PubMed |
| Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia. | Haematologica | 2021 | 33626863 | PubTator, text mining | PubMed |
| SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function. | Inflammation | 2021 | 33624224 | PubTator, text mining | PubMed |
| The role of acalabrutinib in adults with chronic lymphocytic leukemia. | Ther Adv Hematol | 2021 | 33613932 | PubTator, text mining | PubMed |
| Current and novel BTK inhibitors in Waldenström's macroglobulinemia. | Ther Adv Hematol | 2021 | 33613931 | PubTator, text mining | PubMed |
| The SARS-CoV-2 as an instrumental trigger of autoimmunity. | Autoimmun Rev | 2021 | 33610751 | PubTator, text mining | PubMed |
| Circular RNA expression profile in human primary multiple intracranial aneurysm. | Exp Ther Med | 2021 | 33603847 | PubTator, text mining | PubMed |
| Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review. | Cancer Manag Res | 2021 | 33603488 | PubTator, text mining | PubMed |
| Enhancing the Generation of Eomeshi CD8+ T Cells Augments the Efficacy of OX40- and CTLA-4-Targeted Immunotherapy. | Cancer Immunol Res | 2021 | 33593794 | PubTator, text mining | PubMed |
| Richter Syndrome. | Curr Oncol Rep | 2021 | 33580422 | PubTator, text mining | PubMed |
| Targeted immunotherapy for HER2-low breast cancer with 17p loss. | Sci Transl Med | 2021 | 33568521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=53